Tag: Hatch-Waxman Act

Generic Drug Patents: How Exclusivity Periods Vary Across the U.S., EU, Canada, and Beyond
Medications
Generic Drug Patents: How Exclusivity Periods Vary Across the U.S., EU, Canada, and Beyond

Generic drug exclusivity periods vary widely across countries, affecting drug prices and access. Learn how the U.S., EU, Canada, and others regulate generic entry and why these rules matter for patients and healthcare systems.

Read More